CRISNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$7.835 M
$4.02 -8.84%
Close of 7 Aug 2026
Revenue
$9.44M
#3182 by revenue
Earnings
-$7.58M
Loss-making
Shares outstanding
39,978,693
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap
All 160 →Where these numbers come from
Share counts and financials for Curis are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.